|
Tue, 10/28/2025 - 18:39 |
Integral Moleculars Membrane Proteome Array Nears FDA Qualification as a Drug Development Tool |
Integral Molecular |
|
Thu, 10/23/2025 - 18:36 |
Orion and Abzena Announce Exclusive Commercial License for Abzenas Antibody |
Abzena |
|
Wed, 06/25/2025 - 16:09 |
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development |
Bio-Techne |
|
Tue, 06/17/2025 - 13:21 |
Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter |
Integral Molecular |
|
Fri, 05/30/2025 - 18:42 |
Alter Lab Study Uncovers How Certain Antibodies Help Fight Tuberculosis |
Ragon Institute |
|
Tue, 04/22/2025 - 19:33 |
Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in Chicago |
Debiopharm Group |
|
Fri, 04/11/2025 - 04:35 |
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs |
FDA |
|
Tue, 03/11/2025 - 16:05 |
Integral Molecular Launches Paratope-PLUS, a CDR-Scanning Service to Support Robust Patent Claims and Antibody Engineering |
Integral Molecular |
|
Fri, 03/07/2025 - 06:04 |
Integral Moleculars Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors |
Integral Molecular |
|
Fri, 03/07/2025 - 06:03 |
New imaging test could improve how we diagnose and treat lung cancer |
University of A... |
|
Sat, 01/11/2025 - 02:46 |
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform |
UCB |
|
Thu, 06/27/2024 - 09:18 |
BioPharm Internationals June 2024 issue features our VP of Cell Line Development, Simon Keen , discussing how improving the flexibility of cell line development through the utilization of platform approaches and suitable partnerships can reduce potential |
Abzena |
|
Thu, 06/13/2024 - 10:21 |
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease |
AbbVie |
|
Sun, 05/12/2024 - 04:20 |
Antibody Startup Emerges from Stealth: Cell Surface Bio Set to Transform the $10B Antibody Reagent Market |
Integral Molecular |
|
Tue, 02/27/2024 - 19:46 |
Novel protective antibody target identified against Crimean Congo Hemorrhagic Fever virus |
UCR |
|
Fri, 02/09/2024 - 22:03 |
Abzena launches LabZient, an analytical platform to expedite the path to IND for Antibodies |
Abzena |
|
Wed, 12/21/2022 - 01:14 |
The Launch of Chugais New TV Commercial Featuring Tori Matsuzaka Innovation Lab / Antibody Technology |
Chugai |
|
Mon, 12/19/2022 - 19:38 |
Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Board |
Nascent Biotech |
|
Mon, 12/12/2022 - 09:17 |
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 |
Oxis Biotech |
|
Tue, 11/29/2022 - 13:19 |
BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy |
BiondVax Pharma... |
|
Mon, 11/28/2022 - 10:05 |
Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus |
UCR |
|
Wed, 11/02/2022 - 20:36 |
BiondVax to present at Recent Advances in Fermentation Technology (RAFT) 14 Conference |
BiondVax Pharma... |
|
Tue, 11/01/2022 - 14:56 |
Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394 |
Nascent Biotech |
|
Mon, 10/31/2022 - 11:48 |
Neoteryx Provides Microsampling Devices to Fianostics for COVID-19 Antibody Tests in Austria |
Neoteryx |
|
Tue, 10/25/2022 - 06:05 |
Antibody blunts heroins lethality, paving the way for a promising new therapy |
Scripps Research |
